(Q43718029)

English

Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study

scientific article published on 23 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study (English)

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Alessandro Busca

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Giuseppe Milone

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

A Candoni

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Caira

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Giacchino

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

R Fanci

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Delia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Nosari

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Bonini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Cattaneo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

L Melillo

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Caramatti

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

R Scime'

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

R Fanin

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

SEIFEM GROUP (Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne)

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

23 December 2013

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

342-350

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373120%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination antifungal therapy for cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination echinocandin-polyene treatment of murine mucormycosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Decision making in antifungal monotherapy versus combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Rationale for combination antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Toward more effective antifungal therapy: the prospects of combination therapy.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination antifungal therapy: what can and should we expect?

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12161

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43718029&oldid=2102804194"